Table 1 Patient characteristics
Characteristic | Total (n = 204) |
|---|---|
Median (range) | |
Observation period, days | 350 (82–545) |
Age, years | 65 (41–76) |
BMI, kg/m2 | 23.7 (17.2–37.6) |
PSA level, ng/ml | 6.5(3.5–46.4) |
Preoperative MUL, mm | 13.1 (4.5–22.9) |
Estimated prostate volume, g | 38 (7–94) |
Console time, min | 143 (87–351) |
Operation time without console, min | 52 (18–93) |
Intraoperative bleeding, ml* | 70 (10–1243) |
N (%) | |
Clinical stage | |
^T2a | 159 (77.9%) |
T2b | 24 (11.8%) |
^T2c | 21 (10.3%) |
Preoperative hormonal therapy history | 34 (16.7%) |
Lymph node dissection | 58 (28.4%) |
Neurovascular bundle saving | 70 (34.6%) |
Positive surgical margin | 59 (28.9%) |
Leakage at the vesicourethral anastomosis | 17 (8.3%) |